bupropion

(redirected from Wellbutrin xl)
Also found in: Medical.

bu·pro·pi·on

(byo͞o-prō′pē-ŏn′)

A drug, C₁₃H₁₈ClNO, used in its hydrochloride form for the treatment of depression and as an aid in smoking cessation. It is a weak inhibitor of norepinephrine and dopamine reuptake in the central nervous system.

[bu(tyl) + propi(ophen)on(e), a ketone (propio(nic acid) + phen(yl) + -one).]

American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

bupropion

(bjuːˈprəʊpɪɒn)

an antidepressant drug used to help people stop smoking

Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014

Translations

bupropion

n bupropión m

Mentioned in ?

Wellbutrin

References in periodicals archive ?

Support of No Party at 19-21, In re Wellbutrin XL Antitrust Litig.

Causation in Reverse Payment Antitrust Claims

Some of Lupin's recent generic launches include Fayosim Tablets USP (Quartette); Desoximetasone Ointment USP, 0.05% and 0.25% (Topicort); Desoximetasone Cream USP, 0.05% and 0.25% (Topicort LP Emollient Cream (0.05%); Topicort Cream (0.25%); Bupropion Hydrochloride Extended-Release Tablets USP (XL) (Wellbutrin XL); Moxifloxacin Ophthalmic Solution 0.5% (Vigamox); and Quetiapine Fumarate Extended-Release Tablets (Seroquel XR).

Lupin Pharmaceuticals

The approved product is a generic version of Wellbutrin XL of Valeant (NYSE: VRX).

Jubilant Life Sciences receives final approval from US FDA for Bupropion Hydrochloride tablets

In 2007, there were complaints from patients who had been taking the 300 mg dose of an extended-release version of the popular antidepressant, Wellbutrin XL 300, and had recently switched to the generic equivalent, Budeprion XL 300, made by US-based Impax Pharmaceuticals and marketed by the Israeli generic company Teva.

Generics substitution, bioequivalence standards and oversight of international pharmaceutical producers: Complex issues facing the FDA

The company added that the Bupropion HCl ER Tablets USP (XL) are the generic version of WELLBUTRIN XL and are indicated for the treatment of major depressive disorder (MDD).

Mylan Inc wins FDA approval of sANDA for Bupropion Hydrochloride Extended-Release Tablets USP (XL) 300 mg

Review of Therapeutic Equivalence Generic Bupropion XL 300 mg and Wellbutrin XL 300 mg.

Clinical perspectives on the influence of drug formulation on patient tolerability and use of commonly prescribed antidepressants in major depressive disorder

The product is one of the five generic versions of Wellbutrin XL 300-mg tablets that have been approved by the FDA.

Bupropion genetic yanked over bioequivalence

The affected product is Budeprion XL 300 mg, manufactured by Impax Laboratories and marketed by Teva Pharmaceuticals USA--one of the five generic versions of Wellbutrin XL 300-mg tablets that have been approved by the FDA.

Bioequivalence problem results of generic Drug

pharma revenues have dropped 7% to $8.9 billion, primarily due to Avandia, generic Valtrex, and loss of Boniva and WellButrin XL. During the same period, pharma revenues in Europe were up 3% to $7.5 billion, while Emerging Markets were up 24% to $4.0 billion.

Quarterly reports: mega-mergers of 2009 take a toll on earnings

Biovail (TSE: BVF) makes Wellbutrin XL, a widely prescribed anti-depressant, and Ultram ER, an extended-release formulation of an anti-pain medicine.

Valeant Pharmaceuticals annouced today that it had agreed to merge with Biovail Corp. of Canada

Revenue from the antidepressant Wellbutrin XL surged to $58.6 million from $16.6 million, following the acquisition of commercialization rights.

Drugmaker Biovail Corp (Mississauga Ontario) said its third-quarter profit fell 17%, mainly on costs related to the buyout of Prestwick Pharmaceuticals over a year ago and for commercialization rights to several drugs

The researchers also found that they could predict whether subjects were more likely to respond to a different antidepressant, bupropion, also known as Wellbutrin XL.